1. Home
  2. HNVR vs DRUG Comparison

HNVR vs DRUG Comparison

Compare HNVR & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanover Bancorp Inc.

HNVR

Hanover Bancorp Inc.

SELL

Current Price

$21.97

Market Cap

191.4M

Sector

Finance

ML Signal

SELL

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$20.38

Market Cap

228.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNVR
DRUG
Founded
2008
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.4M
228.0M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
HNVR
DRUG
Price
$21.97
$20.38
Analyst Decision
Hold
Strong Buy
Analyst Count
4
9
Target Price
$26.50
★ $107.47
AVG Volume (30 Days)
17.5K
★ 263.1K
Earning Date
10-28-2026
08-17-2026
Dividend Yield
★ 1.82%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 1.40
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.72
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.19
$17.40
52 Week High
$27.94
$123.75

Technical Indicators

Market Signals
Indicator
HNVR
DRUG
Relative Strength Index (RSI) 32.32 26.33
Support Level $20.71 $17.40
Resistance Level $22.39 $58.93
Average True Range (ATR) 0.96 3.39
MACD 0.01 -0.58
Stochastic Oscillator 20.37 7.04

Price Performance

Historical Comparison
HNVR
DRUG

About HNVR Hanover Bancorp Inc.

Hanover Bancorp Inc is a community commercial bank focused on providing personalized and efficient services and products tailored to local needs. The Bank offers a full range of financial services, including a complete suite of consumer, commercial, and municipal banking products such as multifamily and commercial mortgages, government-guaranteed loans, residential loans, business loans, and lines of credit. In addition, it provides customers with access to 24-hour ATM services with no fees, interest-bearing free checking accounts, telephone banking, mobile and internet banking solutions for both consumer and business clients, and safe deposit boxes.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: